Tispa Medical

Partners

Tispa Medical was founded by a number of partners.

Feyecon D&I BV (www.feyecon.com), a development company, strongly connected to the Technical University of Delft and specialized in innovative CO2 applications, in most cases to offer a sustainable alternative for traditional organic solvent processes.

The University Medical Center Groningen (www.umcg.nl), where the idea arose to use supercritical CO2 to replace the intermediate clearing agent step in histo-processing.

The RUG Houdstermaatschappij BV (www.holding.rug.nl) (University Groningen Holding) together with her two venture investment funds Kennis Conversie Fonds (www.holding.rug.nl/kennisconversie) and Noord Tech Venture (www.holding.rug.nl/northtech) have as a target to stimulate scientific technological development and to offer assistance in bringing promising developments to market.

 

Feyecon

 

 

 

 

 

News

  • HET Instrument 2010

    Bezoek Tispa Medical op HET INSTRUMENT
    van 28 sept. t/m 1 okt 2010
    RAI Amsterdam
    di - do van 11.00 - 19.30
    vrij 10.30 - 16.00

    Standnummer 1A 165

    Lees verder voor gratis toegang en openbaar vervoer

  • US Patent awarded

    Tispa Medical is proud to announce that the solvent free and fast histological processing method is now patented in the United States. This opens promising opportunities for expansion of the company.

  • Tispa in Regionaleuropäischer Wirtschafts-Spiegel

    The Tispa Medical process is featured in the October/November 2009 issue of the German magazine Regionaleuropäischer Wirtschafts-Spiegel. Read more and find the link

  • Job Opportunities

    Tispa Medical offers Job opportunities to build a valuable and rewarding career